Hospitalizations for invasive pneumococcal disease among HIV-1-infected adolescents and adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 1, 2010, Pages 128-131

  Kourtis, Athena P ^a   Ellington, Sascha ^a   Bansil, Pooja ^b   Jamieson, Denise J ^a   Posner, Samuel F ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CONRAD ^*  (United States)

Author keywords

HIV 1; Hospitalization; Invasive disease; Pneumococcus; Vaccine

Indexed keywords

ANTIRETROVIRUS AGENT; PCV 7; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RISK; UNITED STATES; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 77956643400     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e8ed15     Document Type: Article

References (15)

1. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis. 2007;20:11-15. (Pubitemid 46052121)
2. Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of HAART, 1995-2000. J Infect Dis. 2005;191:2038-2045. (Pubitemid 40800574)
3. Bliss SJ, O'Brien K, Janoff E, et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet. 2008;8:67-80. (Pubitemid 351620930)
4. Flannery B, Hefferman RT, Harrison LH, et al. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med. 2006;144:1-9. (Pubitemid 46780714)
5. Centers for Disease Control and Prevention. Vaccines and immunizations: coverage with individual vaccines and vaccination series. Available at: http://www.cdc.gov/nip/coverage/NIS/05/toc-05.htm. Accessed November 1, 2008.
6. HIV/AIDS Surveillance Reports. 1994, 1994, 1998, 1999, 2003, 2004. Centers for Disease Control and Prevention, Department of Health and Human Services, Public Health Service. Available at: www.cdc.gov/hiv/topics/ surveillance.htm. Accessed December 1, 2009.
7. Hall IH, Song R, Rhodes S, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
8. Centers for Disease Control and Prevention (CDC). Morbidity and Mortality Weekly Report (MMWR). Epidemiology of HIV/AIDS-United States, 1981-2005. MMWR Morb Mortal Wkly Rep. 2006;55:589-592.
9. United States Census Bureau. Population estimates. Available at: www.census.gov/popest/datasets.html. Accessed November 1, 2008.
10. Kourtis AP, Bansil P, Posner SF, et al. Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994-2003 Nationwide Inpatient Sample. Pediatrics. 2007;120:e236-e243. (Pubitemid 47219472)
11. Albrich WC, Baughman W, Schmotzer B, et al. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, GA, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1569-1576. (Pubitemid 46871503)
12. Abzug MJ, Pelton SI. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox. J Infect Dis. 2009;199:1109-1111.
13. Butler JC, Breiman RF, Lipman HB, et al. Serotype distribution of Streptococcus pneumoniae infection among preschool children in the U. S., 1978-1994: implications for development of a conjugate vaccine. J Infect Dis. 1995;171:885-889.
14. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the U. S. during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196:1346-1354. (Pubitemid 351412007)
15. Madhi S, Klugman KP, Kuwanda L, et al. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis. 2009;199:1168-1176.